Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Diabetes
73%
Patient
46%
Inpatient
40%
Analysis
38%
Insulin
37%
Protein Binding
36%
Somatomedin Binding Protein 1
35%
Therapeutic Procedure
35%
Somatomedin
34%
Cardiovascular Risk
30%
Plasma
30%
Glucose
29%
Somatomedin C
27%
Age
25%
Infection
24%
Diabetes Mellitus
24%
Protein
24%
Synapsin I
24%
Hospital
22%
Patient with Type 2 Diabetes
22%
Blood Pressure
21%
Development
21%
Prevalence
20%
Metabolic Syndrome
19%
Health Care Cost
18%
Somatomedin B
18%
Lipid
17%
Lipoprotein
17%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Insulin Resistance
15%
Mortality
15%
Randomized Controlled Trial
15%
Type 2 Diabetes
15%
Vilanterol
15%
Fluticasone Furoate
15%
Obesity
14%
Insulin Dependent Diabetes Mellitus
14%
Pressure Control
14%
Chronic Obstructive Pulmonary Disease
14%
Biological Marker
13%
Cost-Effectiveness Analysis
13%
Glycemic Control
13%
Diseases
13%
Asthma
13%
Follow up
12%
Nephropathy
12%
Heart Failure
12%
Spontaneous Remission
12%
Diet
12%
Biochemistry, Genetics and Molecular Biology
Insulin-Like Growth Factor-Binding Protein
89%
Insulin-Like Growth Factor
81%
Binding Protein
56%
Insulin
52%
Glucose
35%
Protein
32%
Pregnancy
24%
Association
23%
Atorvastatin
21%
Lipoprotein
21%
Age
20%
Development
18%
Regulatory Mechanism
18%
Glycosylation
17%
Proteome
17%
Statin
16%
Phosphorylation
16%
Cholesterol
16%
Weight
15%
Blood Level
14%
Testosterone
13%
Nested Gene
12%
Human
11%
Cytokine Response
11%
Protein Prenylation
11%
Electric Potential
11%
Dose
10%
Insulin Sensitivity
10%
Lipid
9%
Insulin Resistance
9%
Reductase
9%
Glycemic Control
8%
Sample
8%
Single-Nucleotide Polymorphism
8%
Sex Hormone-Binding Globulin
7%
Placental Mammal
7%
Kidney Function
7%
Glucose Blood Level
7%
Ethnic Difference
7%
Fetus Growth
7%
Growth
7%
Isoform
7%
Mass Spectrometry
7%
Proinflammatory Cytokine
6%
Monochorionic Twins
6%
Interleukin 6
6%
Tumor Necrosis Factors
6%
Prenylation
6%
Dyslipidemia
6%
Mortality
6%
Nursing and Health Professions
Diabetes Mellitus
60%
Control
39%
Patient
34%
Insulin
26%
Heart Failure
23%
Glucose
22%
Non Insulin Dependent Diabetes Mellitus
18%
Hypertension
18%
Analysis
18%
Hyperlipidemia
17%
Nurse Specialist
17%
Odds Ratio
16%
Inpatient
16%
Blood Pressure
14%
Ethnic Groups
13%
Infection
12%
Estimated Glomerular Filtration Rate
12%
Prevalence
11%
Testosterone
11%
Metabolic Syndrome X
11%
Systematic Review
11%
Economic Analysis
11%
Man
11%
Homeostasis Model Assessment
10%
Patient with Diabetes
9%
Severe Acute Respiratory Syndrome
9%
Electric Potential
8%
General Practice
8%
Deterioration
8%
Kidney Disease
8%
Diseases
8%
Practice Guideline
8%
Cost Effectiveness Analysis
7%
Sex Hormone Binding Globulin
7%
Primary Medical Care
7%
Hyperglycemia
7%
Nurse
7%
Treatment Centre
7%
Hospital
7%
Morbidity
7%
Hemoglobin A1c
7%
Obesity
6%
Marker
6%
Clinical Practice
6%
Asthma
6%
Confidence Interval
6%
Chronic Kidney Failure
6%
Albuminuria
6%
Incidence
6%
Quality Adjusted Life Year
6%
